Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin

por De Lorenzo, C, Troise, F, Cafaro, V, D'Alessio, G
Publicado 2007

A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours

por Borriello, M, Laccetti, P, Terrazzano, G, D'Alessio, G, De Lorenzo, C
Publicado 2011

A human, compact, fully functional anti-ErbB2 antibody as a novel antitumour agent

por De Lorenzo, C, Tedesco, A, Terrazzano, G, Cozzolino, R, Laccetti, P, Piccoli, R, D'Alessio, G
Publicado 2004

Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin

por Spalletti-Cernia, D, Sorrentino, R, Di Gaetano, S, Piccoli, R, Santoro, M, D'Alessio, G, Laccetti, P, Vecchio, G
Publicado 2004

Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours

por Gelardi, T, Damiano, V, Rosa, R, Bianco, R, Cozzolino, R, Tortora, G, Laccetti, P, D'Alessio, G, De Lorenzo, C
Publicado 2010

Transport and fate of gaseous pollutants associated with the National Energy Program.

por Altshuller, A P, Johnson, W B, Nader, J S, Niemann, B L, Turner, D B, Wilson, W E, D'Alessio, G
Publicado 1980